These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 305409)

  • 1. Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.
    Levy JG; McMaster R; Kelly B; Whitney RB; Kilburn DG
    Immunology; 1977 Apr; 32(4):475-81. PubMed ID: 305409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between immune complexes and serum from tumor-bearing mice in the suppression of mitogen responses.
    Kilburn DG; Fairhurst M; Levy JG; Whitney RB
    J Immunol; 1976 Nov; 117(5 Pt 1):1612-7. PubMed ID: 1002993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system.
    Whitney RB; Levy JG; Smith AG
    Br J Cancer; 1975 Feb; 31(2):157-63. PubMed ID: 1080668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse T-cell tumour immunoglobulin. I. Antigenic properties and effects on T-cell responses.
    Boylston AW; Watson SR; Anderson RL
    Immunology; 1976 Nov; 31(5):827-35. PubMed ID: 825450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT; Naides SJ; Benacerraf B; Sy MS
    J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of surface immunoglobulin-bearing cells, plasma cells, and tumor development in anaplastic carcinoma-bearing A/J mice.
    Chi DS; Harris NS
    Cancer Res; 1977 Apr; 37(4):1119-24. PubMed ID: 300278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
    McMaster R; Buhler K; Whitney R; Levy JG
    J Immunol; 1977 Jan; 118(1):218-22. PubMed ID: 299757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
    Phillips NE; Parker DC
    J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice.
    Howie S; McBride WH; James K
    Immunology; 1982 May; 46(1):43-8. PubMed ID: 7042550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal activation of Ts cells with antiserum directed against an IGH-1 linked candidate for a T-cell receptor constant region marker.
    Owen FL
    J Supramol Struct; 1980; 14(2):175-82. PubMed ID: 6453257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes.
    Kim KJ; Rollwagen F; Asofsky R; Lefkovits I
    Eur J Immunol; 1984 May; 14(5):476-82. PubMed ID: 6233161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
    Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
    Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.